Restoration of chemosensitivity for doxorubicin and cisplatin in chondrosarcoma in vitro: BCL-2 family members cause chemoresistance

The B-cell lymphoma 2 (BCL2)-inhibitors, ABT-737 and ABT-263, are substrates for P-glycoprotein

(2011) Meike Vogler et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

The antiapoptotic gene survivin is highly expressed in human chondrosarcoma and promotes drug resistance in chondrosarcoma cells in vitro

(2011) Philipp Lechler et al.   BMC CANCER

Navitoclax (ABT-263) Accelerates Apoptosis during Drug-Induced Mitotic Arrest by Antagonizing Bcl-xL

(2011) J. Shi et al.   CANCER RESEARCH

No Haploinsufficiency but Loss of Heterozygosity for EXT in Multiple Osteochondromas

(2010) Christianne M.A. Reijnders et al.   AMERICAN JOURNAL OF PATHOLOGY

Pharmacological Inhibition of the Bcl-2 Family of Apoptosis Regulators as Cancer Therapy

(2010) Alan Richardson et al.   Current Molecular Pharmacology

Molecular characterization of commonly used cell lines for bone tumor research: A trans-European EuroBoNet effort

(2009) Laura Ottaviano et al.   GENES CHROMOSOMES & CANCER

siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells

(2009) Dae Kim et al.   Molecular Cancer

The Bcl-2 Homology Domain 3 Mimetic ABT-737 Targets the Apoptotic Machinery in Acute Lymphoblastic Leukemia Resulting in Synergistic in Vitro and in Vivo Interactions with Established Drugs

(2009) L. M. High et al.   MOLECULAR PHARMACOLOGY

A chondrogenic gene expression signature in mesenchymal stem cells is a classifier of conventional central chondrosarcoma

(2008) S Boeuf et al.   JOURNAL OF PATHOLOGY

The Clinical Approach Towards Chondrosarcoma

(2008) H. Gelderblom et al.   ONCOLOGIST